JAK2 and lung carcinoma: Notably, JAK2 activation modulates STAT3 phosphorylation, it has been shown that nicotine interacts with cell surface α5-nAChR to activate various signaling pathways, including the JAK2/STAT3 pathway, thereby affecting lung cancer progression (Zhang et al., 2017).